skip to main content

Monitored dosage system suitability — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateDispensing and SupplyMonitored dosage system suitabilityGPhC CRA

A care home asks for sodium valproate modified-release tablets to be added to a monitored dosage system for a resident. The resident is stable and takes the tablets twice daily. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Check product suitability before placing modified-release tablets into the system

Some medicines and formulations are unsuitable for monitored dosage systems because of stability, moisture sensitivity or modified-release characteristics. The pharmacist should check product-specific information and the patient's needs before repackaging. Any formulation change requires prescriber involvement.

Reference: BNF; MEP; SmPC